A detailed history of Shell Asset Management CO transactions in Zoetis Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 6,481 shares of ZTS stock, worth $1.07 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,481
Previous 6,533 0.8%
Holding current value
$1.07 Million
Previous $1.13 Million 11.74%
% of portfolio
0.06%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$172.58 - $196.48 $8,974 - $10,216
-52 Reduced 0.8%
6,481 $1.27 Million
Q1 2024

Jul 31, 2024

SELL
$165.67 - $199.94 $4.53 Million - $5.46 Million
-27,328 Reduced 80.71%
6,533 $1.13 Million
Q1 2024

May 14, 2024

SELL
$165.67 - $199.94 $2.42 Million - $2.92 Million
-14,613 Reduced 30.15%
33,861 $5.73 Million
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $4.29 Million - $5.67 Million
-28,361 Reduced 36.91%
48,474 $9.57 Million
Q3 2023

Nov 08, 2023

BUY
$167.14 - $192.77 $34,597 - $39,903
207 Added 0.27%
76,835 $13.4 Million
Q2 2023

Jul 28, 2023

SELL
$160.94 - $186.23 $1.7 Million - $1.96 Million
-10,536 Reduced 12.09%
76,628 $13.2 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $4.34 Million - $5.23 Million
29,857 Added 52.1%
87,164 $14.5 Million
Q4 2022

Feb 07, 2023

SELL
$131.14 - $157.47 $3.32 Million - $3.98 Million
-25,294 Reduced 30.62%
57,307 $8.4 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $3.36 Million - $4.14 Million
-22,663 Reduced 21.53%
82,601 $12.2 Million
Q2 2022

Aug 09, 2022

BUY
$155.97 - $200.09 $1.78 Million - $2.28 Million
11,382 Added 12.12%
105,264 $18.1 Million
Q1 2022

May 04, 2022

BUY
$181.39 - $234.03 $1.01 Million - $1.3 Million
5,542 Added 6.27%
93,882 $17.7 Million
Q4 2021

Feb 09, 2022

BUY
$193.69 - $247.03 $7.77 Million - $9.91 Million
40,120 Added 83.2%
88,340 $21.6 Million
Q3 2021

Nov 04, 2021

BUY
$189.29 - $209.69 $2.1 Million - $2.32 Million
11,086 Added 29.85%
48,220 $9.36 Million
Q2 2021

Aug 12, 2021

SELL
$155.9 - $187.99 $402,222 - $485,014
-2,580 Reduced 6.5%
37,134 $6.92 Million
Q1 2021

May 10, 2021

BUY
$144.0 - $169.39 $1.49 Million - $1.75 Million
10,326 Added 35.14%
39,714 $6.25 Million
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $1.56 Million - $1.73 Million
9,904 Added 50.83%
29,388 $4.86 Million
Q3 2020

Nov 13, 2020

BUY
$137.1 - $165.37 $287,087 - $346,284
2,094 Added 12.04%
19,484 $3.22 Million
Q2 2020

Aug 10, 2020

SELL
$111.92 - $142.53 $1.58 Million - $2.01 Million
-14,127 Reduced 44.82%
17,390 $2.38 Million
Q1 2020

May 11, 2020

SELL
$92.66 - $144.94 $361,744 - $565,845
-3,904 Reduced 11.02%
31,517 $3.71 Million
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $113,227 - $129,785
-974 Reduced 2.68%
35,421 $4.69 Million
Q3 2019

Nov 12, 2019

SELL
$112.57 - $128.43 $188,667 - $215,248
-1,676 Reduced 4.4%
36,395 $4.53 Million
Q2 2019

Aug 12, 2019

BUY
$97.98 - $114.28 $94,550 - $110,280
965 Added 2.6%
38,071 $4.32 Million
Q1 2019

May 09, 2019

BUY
$81.56 - $100.67 $259,605 - $320,432
3,183 Added 9.38%
37,106 $3.74 Million
Q4 2018

Feb 13, 2019

SELL
$79.28 - $95.27 $1.07 Million - $1.29 Million
-13,545 Reduced 28.54%
33,923 $2.9 Million
Q3 2018

Nov 13, 2018

SELL
$83.5 - $93.23 $147,043 - $164,178
-1,761 Reduced 3.58%
47,468 $4.35 Million
Q2 2018

Aug 10, 2018

BUY
$79.9 - $89.2 $257,597 - $287,580
3,224 Added 7.01%
49,229 $4.19 Million
Q1 2018

May 14, 2018

SELL
$71.51 - $84.69 $187,141 - $221,633
-2,617 Reduced 5.38%
46,005 $3.84 Million
Q4 2017

Feb 09, 2018

BUY
$63.24 - $72.8 $1.65 Million - $1.9 Million
26,077 Added 115.67%
48,622 $3.5 Million
Q3 2017

Oct 20, 2017

SELL
$59.73 - $65.4 $3.43 Million - $3.76 Million
-57,504 Reduced 71.84%
22,545 $1.44 Million
Q3 2017

Oct 18, 2017

BUY
$59.73 - $65.4 $4.78 Million - $5.24 Million
80,049
80,049 $2.96 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.